{"entity":{"type":"insider","cik":"0001686530","url":"/insider/0001686530","json_url":"/insider/0001686530.json","name":"Toledano Miranda Jayne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2022-01-03","last":"2025-12-30","span_basis":"filed_date"},"name_variants":[{"name":"Toledano Miranda Jayne","source":"filing","n_filings":6,"first_seen":"2022-01-03","last_seen":"2025-12-30"}],"transactions":[{"id":4490388,"accession":"0001178913-25-004125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-25-004125","line_url":"/filing/0001178913-25-004125#line-1","is_derivative":false,"issuer_cik":"0001638097","issuer_name":"Entera Bio Ltd.","issuer_ticker":"ENTX","issuer_name_source":null,"issuer_url":"/issuer/0001638097","owner_cik":"0001686530","owner_name":"Toledano Miranda Jayne","owner_display_name":"Toledano Miranda Jayne","owner_url":"/insider/0001686530","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares, par value NIS 0.0000769 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":1.8102,"price_display":"1.81","price_state":"stated","total_value":19912.2,"total_display":"19,912.20","total_whole":"19,912","shares_owned_after":426575.0,"shares_owned_after_display":"426,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-29","filed_date":"2025-12-30","scope":"insider"},{"id":8362000,"accession":"0001178913-23-003971","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-23-003971","line_url":"/filing/0001178913-23-003971#line-1","is_derivative":false,"issuer_cik":"0001638097","issuer_name":"Entera Bio Ltd.","issuer_ticker":"ENTX","issuer_name_source":null,"issuer_url":"/issuer/0001638097","owner_cik":"0001686530","owner_name":"Toledano Miranda Jayne","owner_display_name":"Toledano Miranda Jayne","owner_url":"/insider/0001686530","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares, par value NIS 0.0000769 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23952.0,"shares_display":"23,952","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":17005.92,"total_display":"17,005.92","total_whole":"17,006","shares_owned_after":110752.0,"shares_owned_after_display":"110,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-27","scope":"insider"},{"id":8460564,"accession":"0001178913-23-001348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-23-001348","line_url":"/filing/0001178913-23-001348#line-1","is_derivative":false,"issuer_cik":"0001638097","issuer_name":"Entera Bio Ltd.","issuer_ticker":"ENTX","issuer_name_source":null,"issuer_url":"/issuer/0001638097","owner_cik":"0001686530","owner_name":"Toledano Miranda Jayne","owner_display_name":"Toledano Miranda Jayne","owner_url":"/insider/0001686530","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares, par value NIS 0.0000769 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":30300.0,"total_display":"30,300.00","total_whole":"30,300","shares_owned_after":86800.0,"shares_owned_after_display":"86,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-06","scope":"insider"},{"id":6241380,"accession":"0001178913-22-003988","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-22-003988","line_url":"/filing/0001178913-22-003988#line-1","is_derivative":false,"issuer_cik":"0001638097","issuer_name":"Entera Bio Ltd.","issuer_ticker":"ENTX","issuer_name_source":null,"issuer_url":"/issuer/0001638097","owner_cik":"0001686530","owner_name":"Toledano Miranda Jayne","owner_display_name":"Toledano Miranda Jayne","owner_url":"/insider/0001686530","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares, par value NIS 0.0000769 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.5317,"price_display":"0.53","price_state":"stated","total_value":26585.0,"total_display":"26,585.00","total_whole":"26,585","shares_owned_after":56800.0,"shares_owned_after_display":"56,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-14","scope":"insider"},{"id":6422120,"accession":"0001178913-22-000165","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-22-000165","line_url":"/filing/0001178913-22-000165#line-1","is_derivative":false,"issuer_cik":"0001638097","issuer_name":"Entera Bio Ltd.","issuer_ticker":"ENTX","issuer_name_source":null,"issuer_url":"/issuer/0001638097","owner_cik":"0001686530","owner_name":"Toledano Miranda Jayne","owner_display_name":"Toledano Miranda Jayne","owner_url":"/insider/0001686530","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.0000769 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6800.0,"shares_display":"6,800","price_per_share":2.7899,"price_display":"2.79","price_state":"stated","total_value":18971.32,"total_display":"18,971.32","total_whole":"18,971","shares_owned_after":6800.0,"shares_owned_after_display":"6,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-19","scope":"insider"},{"id":6536629,"accession":"0001104659-22-000437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-000437","line_url":"/filing/0001104659-22-000437#line-1","is_derivative":false,"issuer_cik":"0001468929","issuer_name":"NEXGEL, INC.","issuer_ticker":"NXGL","issuer_name_source":null,"issuer_url":"/issuer/0001468929","owner_cik":"0001686530","owner_name":"Toledano Miranda Jayne","owner_display_name":"Toledano Miranda Jayne","owner_url":"/insider/0001686530","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1819.0,"shares_display":"1,819","price_per_share":5.49,"price_display":"5.49","price_state":"stated","total_value":9986.31,"total_display":"9,986.31","total_whole":"9,986","shares_owned_after":1819.0,"shares_owned_after_display":"1,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2022-01-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001638097","name":"Entera Bio Ltd.","url":"/issuer/0001638097","role":"Director, Officer (Chief Executive Officer)","n_filings":5,"first_seen":"2022-01-19","last_seen":"2025-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001468929","name":"NEXGEL, INC.","url":"/issuer/0001468929","role":"Director","n_filings":1,"first_seen":"2022-01-03","last_seen":"2022-01-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001686530","retrieved_at":"2026-08-23T09:45:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}